Global assessment of keratoconus prevalence in children and adolescents
Official title: The K-Map Study, Global Prevalence of KC
Run by University Hospital, Geneva · NCT03115710 · Data updated 2026-11-12
This study is trying to find out how common keratoconus is in kids and teens around the world by using special eye imaging techniques.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 6 Years to 23 Years |
| Sex | All |
| Enrollment | 20000 (estimated) |
| Sponsor | University Hospital, Geneva Academic / other |
| Locations | 12 sites (Los Angeles, California and 11 other locations) |
| Status | Recruiting |
| Started | December 28, 2015 |
| Main results expected | February 1, 2030 |
| Study ends | February 1, 2030 |
| Registry record updated | August 11, 2025 |
| Trial ID | NCT03115710 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children and adolescents aged 6 to 20 years who are attending medical appointments for non-ophthalmologic reasons.
✕Probably not a fit
Patients with preexisting ocular diseases or conditions, as well as those who are pregnant or breastfeeding, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the prevalence of keratoconus in children and adolescents across various global regions using advanced tomographic imaging techniques. By conducting bilateral corneal tomography examinations on participants aged 6 to 20 years who are visiting for non-ophthalmologic reasons, the study seeks to determine if the actual prevalence of keratoconus is higher than previously reported. The research will take place in multiple cities across North America, South America, Asia, and Europe, providing a comprehensive view of the condition's prevalence worldwide.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and awareness of keratoconus prevalence, potentially influencing early detection and treatment strategies.
How similar studies have gone: While there have been studies on keratoconus, this approach of assessing global prevalence using modern imaging techniques is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female, 6-23 years of age. * Subjects seen for a non-ophthalmic appointment * Provide signed and dated patient consent form (signed by parents / legal guardians). * Willing to comply with all study procedures and be available for the duration of the study Exclusion Criteria: * Patients with a preexisting ocular disease / condition * Pregnancy or breastfeeding
Where it's running
-
USC Roski Eye Institute
Los Angeles, California, United States Recruiting -
Eye Hospital of Wenzhou Medical College
Wenzhou, China Recruiting - Zagreb, Croatia Recruiting
- Alexandria, Egypt Recruiting
- Homburg, Germany Recruiting
- Isfahan, Iran Recruiting
Show 6 more locations
- Amman, Jordan Recruiting
- Monterrey, Mexico Recruiting
- Lima, Peru Recruiting
- Bukhara, Uzbekistan Recruiting
-
Ufa Eye Research Intitute
Ufa, Russia Completed -
King Saud University
Riyadh, Saudi Arabia Completed
Study contacts
- Study coordinator: Farhad Hafezi, MDPhD
- Email: fhafezi@elza-institute.com
- Phone: +41 44 741 81 81
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Corneal Crosslinking to Treat Progressive Keratoconus or Corneal Ectasia
This study tests two different light durations used in corneal crosslinking to see which better helps people with keratoconus or corneal ectasia.
-
Brillouin hydration mapping to study cornea health
Researchers test a Brillouin microscope to see if it can measure corneal water content in healthy people and those with eye conditions.
-
Same-day bilateral corneal cross-linking for keratoconus
This trial tests whether performing corneal cross-linking in both eyes on the same day is safe and feasible for people with keratoconus.
-
A Smart Aperture Lens to Help Keratoconus and Presbyopia
This study tests the NOA lens, a custom scleral contact lens with a central aperture, to see if it improves vision for people with keratoconus and presbyopia.
-
GLK-221 eye drops for keratoconus
This trial will test whether twice-daily GLK-221 eye drops are safe and help adults aged 18–55 with keratoconus compared with a placebo.
-
Corneal wavefront-guided PRK plus epi-off CXL versus PTK plus epi-off CXL for keratoconus
This trial tests whether adding corneal wavefront-guided PRK to epi-off corneal cross-linking gives better vision than PTK plus epi-off CXL in adults with keratoconus.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.